Valneva SE (VALN) Interest Expenses (2020 - 2026)

Valneva SE (VALN) reported Interest Expenses of -$6.0 million for Q1 2026, up 5.21% on a YoY basis from -$5.7 million in Q1 2025, and down 120.82% sequentially from $28.6 million in Q4 2025.

Valneva SE (VALN) Interest Expenses (2020 - 2026) Analysis & Trends

Valneva SE (VALN) has 7 years of Interest Expenses data on file, last reported at -$6.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Interest Expenses rose 5.21% year-over-year to -$6.0 million; the trailing twelve-month figure through Mar 2026 stood at $50.0 million (up 108.33% YoY), and the FY2025 full-year result was $48.8 million, up 87.76% from the prior year.
  • Interest Expenses declined to -$6.0 million in Q1 2026, from $28.6 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $5.8 billion in Q3 2023 to a low of -$5.8 billion in Q2 2023.
  • A 5-year average of $6.1 million and a median of -$2.5 million in 2022 frame the typical range for Interest Expenses.
  • Peak annual rise in Interest Expenses reached 231663.58% in 2023, while the deepest fall reached 822382.75% in 2023.
  • Tracing VALN's Interest Expenses over 5 years: stood at $26.1 million in 2022, then surged by 47.5% to $38.5 million in 2023, then plunged by 82.52% to $6.7 million in 2024, then surged by 325.35% to $28.6 million in 2025, then plunged by 120.82% to -$6.0 million in 2026.
  • Business Quant data shows VALN's Interest Expenses at -$6.0 million in Q1 2026, $28.6 million in Q4 2025, and $31.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -42,141.15
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 100,000.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 32.89 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 420.30 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 28.30 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 1.17 Bn
10 Valneva SE 811.46 Mn 688.23 Mn 5.08 Mn -5.96 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -5.96 Mn
Mar 31, 2026 -5.96 Mn
Dec 31, 2025 28.64 Mn
Dec 31, 2025 28.64 Mn
Sep 30, 2025 31.27 Mn
Sep 30, 2025 31.27 Mn
Jun 30, 2025 -3.93 Mn
Jun 30, 2025 -3.93 Mn
Mar 31, 2025 -6.29 Mn
Mar 31, 2025 -6.29 Mn
Dec 31, 2024 6.73 Mn
Dec 31, 2024 6.73 Mn
Sep 30, 2024 31.22 Mn
Sep 30, 2024 31.22 Mn
Jun 30, 2024 -10.07 Mn
Jun 30, 2024 -10.07 Mn
Mar 31, 2024 -7.65 Mn
Mar 31, 2024 -7.65 Mn
Dec 31, 2023 38.52 Mn
Dec 31, 2023 38.52 Mn